Zithromax chlamydia pneumoniae infections with Chlamydia pneumoniae have zithromax chlamydia pneumoniae implicated in the development of chronic diseases, such as pneumoniae and asthma. Although azithromycin, clarithromycin, pneumoniae levofloxacin are frequently used for the treatment of respiratory C. In this study, we investigated the effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on zithromax chlamydia pneumoniae viability of C.
We found that a day treatment with azithromycin, clarithromycin, and levofloxacin at concentrations comparable to those achieved in the pulmonary epithelial lining fluid pneumoniae but did not eliminate C.
All three antibiotics decreased levels of interleukin-6 Link and IL-8 in HEp-2 cells, but zithromax chlamydia pneumoniae effect appeared to be secondary to the antichlamydial activity, as the cytokine levels correlated with the concentrations of microorganisms.
The levels of IL-1beta, IL-4, IL, tumor necrosis factor alpha, and zithromax chlamydia pneumoniae interferon were too zithromax chlamydia to assess the effect of antibiotics.
These data suggest zithromax chlamydia pneumoniae the dosage and duration of antibiotic therapy currently being used may not be sufficient to eradicate a putative chronic C.
2018 ©